{"html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20050901%2Fp3\" title=\"\u30e1\u30c8\u30ea\u30d6\u30b8\u30f3Metribuzin\u306e\u518d\u8a55\u4fa1 - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","width":"100%","categories":[],"description":"Re-evaluation of Metribuzin August 30, 2005 http://www.pmra-arla.gc.ca/english/pdf/pacr/pacr2005-07-e.pdf \u9664\u8349\u5264\u3002\u767b\u9332\u3092\u7d99\u7d9a\u3002 45\u65e5\u9593\u30b3\u30e1\u30f3\u30c8\u52df\u96c6 ACSH","image_url":null,"type":"rich","blog_url":"https://uneyama.hatenadiary.jp/","url":"https://uneyama.hatenadiary.jp/entry/20050901/p3","height":"190","version":"1.0","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","provider_url":"https://hatena.blog","provider_name":"Hatena Blog","author_url":"https://blog.hatena.ne.jp/uneyama/","title":"\u30e1\u30c8\u30ea\u30d6\u30b8\u30f3Metribuzin\u306e\u518d\u8a55\u4fa1","published":"2005-09-01 00:00:03","author_name":"uneyama"}